Archer Daniels' Yerbalatina Buyout to Boost Natural ProductsHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Archer Daniels' Yerbalatina Buyout to Boost Natural ProductsZacks Equity ResearchZacksJanuary 8, 2020ReblogShareTweetShareArcher Daniels Midland CompanyADM recently bought Yerbalatina Phytoactives, a Brazilian-based pioneering natural plant-based extracts maker. With this buyout, the company will be able to enhance its presence in Brazil, where it has an extensive human and animal nutrition business. Through this buyout, Archer Daniels will be able to serve customers with healthy and natural-source products in the foods and beverages space.Notably, Yerbalatina uses proprietary cool-drying technology to transform fruits, vegetables and plants like acerola, acai, green coffee into a wide range of extracts. Moreover, it has a range of more than 100 botanical products and solutions, which include healthy ingredients as well as organic powdered fruits, food colorings, vegetable milks and nutritional extracts.Furthermore, Archer Daniels is likely to benefit from Yerbalatina’s natural botanical extracts that comprise organic-certified ingredients, R&D competencies and expertise. This will reinforce the company’s leadership in science-based microbiome solutions for human and animal wellness.We note that the global retail market for foods, beverages and supplements, highlighting health & wellness concepts, is flourishing and is anticipated to reach $750 billion. Impressively, the addition of Yerbalatina to the company’s portfolio is an important tool and will continue to leverage the power of nature to enrich human and animal health.Meanwhile, Archer Daniels’ three strategic pillars — optimize, drive and growth — as well as Project Readiness initiative to drive overall growth bode well. The Readiness goals of improving business, standardizing functions and enriching consumers’ experience are on track.The company’s strategic pillars, guided and supported by the Readiness program, are focused on accelerating and enhancing competitiveness. Management is optimistic about Archer Daniels’ leadership in key global trends like flexitarian diets, nutrition and sustainable materials. Moreover, the company is focused on investing in assets and technological capabilities to serve customers efficiently as well as boost growth.Price Performance & Zacks RankShares of the agricultural products company have gained 8% in the past six months compared with the industry’s rise of 5.4%.Archer Daniels currently carries a Zacks Rank #3 (Hold).Better-Ranked Consumer Staples StocksLamb Weston Holdings, Inc LW has an expected long-term earnings growth rate of 7.9% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.General Mills, Inc GIS has an expected long-term earnings growth rate of 7% and carries a Zacks Rank #2 (Buy).The Hain Celestial Group, Inc HAIN delivered a positive earnings surprise of 14.3% in the last reported quarter. It currently carries a Zacks Rank #2.The Hottest Tech Mega-Trend of AllLast year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.See Zacks' 3 Best Stocks to Play This Trend >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Hain Celestial Group, Inc. (HAIN) : Free Stock Analysis Report Lamb Weston Holdings Inc. (LW) : Free Stock Analysis Report General Mills, Inc. (GIS) : Free Stock Analysis Report Archer Daniels Midland Company (ADM) : Free Stock Analysis Report To read this article on Zacks.com click here.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoIs Link Administration Holdings Limited (ASX:LNK) Trading At A 50% Discount?Simply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideobioMérieux S.A. Full-Year Results: Here's What Analysts Are Forecasting For Next YearSimply Wall St.Richard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance